Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00976677

Public ClinicalTrials.gov record NCT00976677. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 2:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Double-Blind Placebo Controlled Phase II Trial Evaluating Erlotinib in Non-Smoking Patients With (Bevacizumab-Eligible and Ineligible) Advanced Non-Small Cell Lung Cancer (NSCLC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized phase II trial studies how well carboplatin, paclitaxel, and bevacizumab work with or without erlotinib hydrochloride in treating non-smokers with advanced non-small cell lung cancer. Drugs used in chemotherapy, such as carboplatin and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Erlotinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. It is not yet known whether giving combination chemotherapy together with bevacizumab is more effective with or without erlotinib hydrochloride in treating patients with non-small cell lung cancer.

Study identification

NCT ID
NCT00976677
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Enrollment
10 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2010 (Type not available)
Primary completion
Jul 2012 (Actual)
Completion
Nov 2013 (Actual)
Last update posted
May 30, 2014

2010 – 2013

United States locations

U.S. sites
108
U.S. states
12
U.S. cities
68
Facility City State ZIP Site status
The Medical Center of Aurora Aurora Colorado 80012 —
Boulder Community Hospital Boulder Colorado 80301 —
Penrose-Saint Francis Healthcare Colorado Springs Colorado 80907 —
Saint Anthony Central Hospital Denver Colorado 80204 —
Porter Adventist Hospital Denver Colorado 80210 —
Exempla Saint Joseph Hospital Denver Colorado 80218 —
Presbyterian - Saint Lukes Medical Center - Health One Denver Colorado 80218 —
Rose Medical Center Denver Colorado 80220 —
Colorado Cancer Research Program CCOP Denver Colorado 80224-2522 —
Swedish Medical Center Englewood Colorado 80110 —
Saint Mary's Hospital and Regional Medical Center Grand Junction Colorado 81502 —
North Colorado Medical Center Greeley Colorado 80631 —
Sky Ridge Medical Center Lone Tree Colorado 80124 —
Longmont United Hospital Longmont Colorado 80501 —
McKee Medical Center Loveland Colorado 80539 —
Saint Mary Corwin Medical Center Pueblo Colorado 81004 —
North Suburban Medical Center Thornton Colorado 80229 —
Exempla Lutheran Medical Center Wheat Ridge Colorado 80033 —
Saint Francis Hospital and Medical Center Hartford Connecticut 06105 —
Illinois CancerCare-Bloomington Bloomington Illinois 61701 —
Saint Joseph Medical Center Bloomington Illinois 61701 —
Graham Hospital Association Canton Illinois 61520 —
Illinois CancerCare-Canton Canton Illinois 61520 —
Illinois CancerCare-Carthage Carthage Illinois 62321 —
Memorial Hospital Carthage Illinois 62321 —
Eureka Hospital Eureka Illinois 61530 —
Illinois CancerCare-Eureka Eureka Illinois 61530 —
Illinois CancerCare Galesburg Galesburg Illinois 61401 —
Ingalls Memorial Hospital Harvey Illinois 60426 —
Illinois CancerCare-Havana Havana Illinois 62644 —
Mason District Hospital Havana Illinois 62644 —
Illinois CancerCare-Kewanee Clinic Kewanee Illinois 61443 —
Illinois CancerCare-Macomb Macomb Illinois 61455 —
Mcdonough District Hospital Macomb Illinois 61455 —
Garneau, Stewart C MD (UIA Investigator) Moline Illinois 61265 —
Porubcin, Michael MD (UIA Investigator) Moline Illinois 61265 —
Sharis, Christine M MD (UIA Investigator) Moline Illinois 61265 —
Spector, David MD (UIA Investigator) Moline Illinois 61265 —
Stoffel, Thomas J MD (UIA Investigator) Moline Illinois 61265 —
Trinity Medical Center Moline Illinois 61265 —
Illinois CancerCare-Monmouth Monmouth Illinois 61462 —
Bromenn Regional Medical Center Normal Illinois 61761 —
Community Cancer Center Foundation Normal Illinois 61761 —
Illinois CancerCare-Community Cancer Center Normal Illinois 61761 —
Illinois CancerCare-Ottawa Clinic Ottawa Illinois 61350 —
Ottawa Regional Hospital and Healthcare Center Ottawa Illinois 61350 —
Pekin Cancer Treatment Center Pekin Illinois 61554 —
Pekin Hospital Pekin Illinois 61554 —
Illinois CancerCare-Pekin Pekin Illinois 61603 —
Methodist Medical Center of Illinois Peoria Illinois 61603 —
Proctor Hospital Peoria Illinois 61614 —
Illinois CancerCare-Peoria Peoria Illinois 61615 —
Illinois Oncology Research Association CCOP Peoria Illinois 61615 —
OSF Saint Francis Medical Center Peoria Illinois 61637 —
Illinois CancerCare-Peru Peru Illinois 61354 —
Illinois Valley Hospital Peru Illinois 61354 —
Illinois CancerCare-Princeton Princeton Illinois 61356 —
Perry Memorial Hospital Princeton Illinois 61356 —
Illinois CancerCare-Spring Valley Spring Valley Illinois 61362 —
McFarland Clinic Ames Iowa 50010 —
Constantinou, Costas L MD (UIA Investigator) Bettendorf Iowa 52722 —
Cedar Rapids Oncology Association Cedar Rapids Iowa 52403 —
Mercy Hospital Cedar Rapids Iowa 52403 —
Oncology Associates at Mercy Medical Center Cedar Rapids Iowa 52403 —
Siouxland Hematology Oncology Associates Sioux City Iowa 51101 —
Mercy Medical Center-Sioux City Sioux City Iowa 51104 —
Saint Luke's Regional Medical Center Sioux City Iowa 51104 —
Greater Baltimore Medical Center Baltimore Maryland 21204 —
Saint Joseph Mercy Hospital Ann Arbor Michigan 48106-0995 —
Michigan Cancer Research Consortium Community Clinical Oncology Program Ann Arbor Michigan 48106 —
Oakwood Hospital Dearborn Michigan 48124 —
Saint John Hospital and Medical Center Detroit Michigan 48236 —
Hurley Medical Center Flint Michigan 48502 —
Genesys Regional Medical Center-West Flint Campus Flint Michigan 48532 —
Allegiance Health Jackson Michigan 49201 —
Sparrow Hospital Lansing Michigan 48912 —
Saint Mary Mercy Hospital Livonia Michigan 48154 —
Saint Joseph Mercy Oakland Pontiac Michigan 48341-2985 —
Saint Joseph Mercy Port Huron Port Huron Michigan 48060 —
Saint Mary's of Michigan Saginaw Michigan 48601 —
Saint John Macomb-Oakland Hospital Warren Michigan 48093 —
Essentia Health Duluth Clinic CCOP Duluth Minnesota 55805 —
Essentia Health Saint Mary's Medical Center Duluth Minnesota 55805 —
Miller-Dwan Hospital Duluth Minnesota 55805 —
Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County Mount Holly New Jersey 08060 —
Newark Beth Israel Medical Center Newark New Jersey 07112 —
Virtua West Jersey Hospital Voorhees Voorhees Township New Jersey 08043 —
Mercy Medical Center Canton Ohio 44708 —
Aultman Health Foundation Canton Ohio 44710 —
Case Western Reserve University Cleveland Ohio 44106 —
Lake University Ireland Cancer Center Mentor Ohio 44060 —
Southwest General Health Center Ireland Cancer Center Middleburg Heights Ohio 44130 —
UHHS-Chagrin Highlands Medical Center Orange Ohio 44122 —
UHHS-Westlake Medical Center Westlake Ohio 44145 —
Bryn Mawr Hospital Bryn Mawr Pennsylvania 19010 —
Geisinger Medical Center Danville Pennsylvania 17822-2001 —
Geisinger Medical Center-Cancer Center Hazelton Hazleton Pennsylvania 18201 —
Paoli Memorial Hospital Paoli Pennsylvania 19301 —
Abramson Cancer Center of The University of Pennsylvania Philadelphia Pennsylvania 19104 —
Geisinger Medical Group State College Pennsylvania 16801 —
Geisinger Wyoming Valley Wilkes-Barre Pennsylvania 18711 —
Lankenau Hospital Wynnewood Pennsylvania 19096 —
Mainline Health CCOP Wynnewood Pennsylvania 19096 —
Parkland Memorial Hospital Dallas Texas 75235 —
Zale Lipshy University Hospital Dallas Texas 75235 —
Saint Paul Hospital Dallas Texas 75390 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
Dean Hematology and Oncology Clinic Madison Wisconsin 53717 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00976677, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 30, 2014 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00976677 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →